Webinar Summary: Capitol Hill Forecast — What Should MCRCs Prepare For?
Hosted by AMRC, this timely webinar offered insights into the evolving federal policy and funding landscape affecting multisite clinical research corporations (MCRCs), with a strong focus on strategic advocacy and the challenges ahead.
Capitol Hill Forecast – What Should MCRCs Prepare For?
Join Patrick Cooney, a seasoned expert with bipartisan insight into healthcare policy, as we explore the federal government’s priorities and funding outlook for clinical research.
Member Spotlight: Helios on patient-centered oncology care and addressing ‘One-and-Done’
In a recent interview with E.B. McLindon, CEO of Helios Clinical Research and Director at the Association for Multi-Site Research Corporations (AMRC), McLindon shared his perspective on the mindset needed in the research industry
AMRC responds to an FDA consultation
As part of AMRC’s role to advocate for multisite clinical research corporations (MCRC), we responded to the FDA’s consultation: Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Guidance for Industry – Draft Guidance.
Why Do Sponsors and CROs Need a Trade Association Dedicated to Multisite Research Corporations?
The clinical trial ecosystem has become increasingly complex, with the number of drugs in development nearly doubling between 2012 and 2022. This growth, coupled with rising patient recruitment demands and the need for diverse trial endpoints, has highlighted the limitations of the traditional site model.
Operational inefficiency in clinical research: what is it costing Sponsors and CROs?
The Association of Multisite Research Corporations (AMRC) welcomes a panel of experts to discuss the financial and operational impact of inefficiency in clinical trials. We’ll be joined by representatives from regulatory, academic, pharma, and trial sites, who will share their perspectives on the challenges facing the industry and possible solutions to streamline trials, improve data quality, and bring therapies to patients faster.
